David Bharucha
Chief Tech/Sci/R&D Officer at MILESTONE PHARMACEUTICALS INC.
Net worth: 23 890 $ as of 29/04/2024
Profile
David B.
Bharucha is currently the Chief Medical Officer at Milestone Pharmaceuticals, Inc. Prior to this, he worked as the VP-Clinical Development, Research & Development at Allergan Ltd.
(Ireland) from 2018 to 2021.
Dr. Bharucha received his undergraduate degree from Haverford College and his doctorate degree from The University of Chicago.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
14/04/2024 | 15,120 ( 0.03% ) | 23 890 $ | 29/04/2024 |
David Bharucha active positions
Companies | Position | Start |
---|---|---|
MILESTONE PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 14/02/2022 |
Former positions of David Bharucha
Companies | Position | End |
---|---|---|
ALLERGAN PLC | Corporate Officer/Principal | 31/12/2020 |
Training of David Bharucha
The University of Chicago | Doctorate Degree |
Haverford College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MILESTONE PHARMACEUTICALS INC. | Health Technology |
Private companies | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- David Bharucha